References
- Chancellor AM, Mitchell JD, Swingler RJ. The first description of idiopathic progressive bulbar palsy. J Neurol Neurosurg Psychiatry. 1993;56:1270.
- Charcot J-M. Leçon sur les maladies du système nerveux Tome II. 4th. Paris: A. Delahaye et E. Lecrosnier; 1885. 251. http://www.archive.org/texts/flipbook/flippy.php?id=leonssurlesmal02char
- Duchenne de Boulogne G. Paralysie musculaire progressive de la langue, du voile du palais et des 1evres. Archiv Gen Med. 1860;2:283–96.
- Brooks BR, Miller RG, Swash M, Munsat TL. El Escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis. Amyotroph Lateral Scler Other Motor Neuron Disord. 2000;1:293–9.
- Belsh JM. Diagnostic challenges in ALS. Neurology. 1999;53(Suppl 5):S26–30.
- Adams RD, Victor MV, Ropper AH. Adams RD, Victor MV, Ropper AH, Brown RH. Principles of Neurology. 8th. New York: McGraw Hill; 2005:940.
- Clarke C, Howard R, Rossor M, Shorvon S. Neurology: A Queen Square Textbook. 1st. Oxford: Blackwell Publishing Ltd; 2009:378.
- Neary D, Snowden JS, Gustafson L, Passant U, Stuss D, Black S, . Frontotemporal lobar degeneration: a consensus on clinical diagnostic criteria. Neurology. 1998;51:1546–54.
- Chiò A, Mora G, Calvo A, Mazzini L, Bottacchi E, Mutani R, on behalf of the PARALS. Epidemiology of ALS in Italy: a 10-year prospective population-based study Neurology. 2009;72:725–31.
- Zoccolella S, Beghi E, Palagano G, Fraddosio A, Guerra V, Samarelli V, . Riluzole and amyotrophic lateral sclerosis survival: a population-based study in southern Italy. Neurology. 2006;66(Suppl 2):A231.
- O'Toole O, Traynor B, Brennan P, Sheehan C, Frost E, Corr B, . Epidemiology and clinical features of amyotrophic lateral sclerosis in Ireland between 1995 and 2004. J Neurol Neurosurg Psychiatry. 2008;79:30–2. Epub 2007, Jul 18.
- van den Berg JP, Kalmijn S, Lindeman E, Veldink JH, de Visser M, van der Graaff MM, . Multidisciplinary ALS care improves quality of life in patients with ALS. Neurology. 2005;65:1264–7.
- Bourke SC, Bullock RE, Williams TL, Shaw PJ, Gibson GJ. Non-invasive ventilation in ALS: indications and effect on quality of life. Neurology. 2003;61:171–7.
- Kleopa KA, Sherman M, Neal B, Romano GJ, Heiman-Patterson T. BiPap improves survival and rate of pulmonary function decline in patients with ALS. J Neurol Sci. 1999;164:82–8.
- Olney RK, Murphy J, Forshew D, Garwood E, Miller BL, Langmore S, . The effects of executive and behavioral dysfunction on the course of ALS. Neurology. 2005;65:1774–7.
- Traynor BJ, Codd MB, Corr B, Forde C, Frost E, Hardiman OM. Clinical features of amyotrophic lateral sclerosis according to the El Escorial and Airlie House diagnostic criteria: a population-based study. Arch Neurol. 2000;57:1171–6.
- Logroscino G, Traynor BJ, Hardiman O, Chio’ A, Couratier P, Mitchell JD, . Descriptive epidemiology of amyotrophic lateral sclerosis: new evidence and unsolved issues. J Neurol Neurosurg Psychiatry. 2008;79:6–11.
- Bensimon G, Lacomblez L, Meininger V. A controlled trial of riluzole in amyotrophic lateral sclerosis. N Engl J Med. 1994;330:585–591.
- Zoccolella S, Beghi E, Palagano G, Fraddosio A, Guerra V, Samarelli V, . Riluzole and amyotrophic lateral sclerosis survival: a population-based study in southern Italy. Eur J Neurol. 2007;14:262–8.